img

Global Exosome Therapy Market Insights, Forecast to 2034

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Exosome Therapy Market Insights, Forecast to 2034

Exosome technology can directly release specific miRNAs into tumor cells for the treatment of cholangiocarcinoma.
Market Analysis and InsightsGlobal Exosome Therapy Market
Global Exosome Therapy market is expected to reach to US$ 1937.5 million in 2024, with a positive growth of %, compared with US$ 1897.3 million in 2022. Backed with the increasing demand from downstream industries, Exosome Therapy industry is evaluated to reach US$ 2764 million in 2029. The CAGR will be 6.1% during 2024 to 2029.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers
This report presents an overview of global Exosome Therapy market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Exosome Therapy market with multiple angles. Items like regional revenue from 2018 to 2029 and companies’ revenue and gross margin from 2018 to 2024 are analyzed. In addition, revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Companies, Type, Application and Regions Listed in the Report



By Company


United Therapeutics Corporation
Codiak BioSciences
EngEx™
Esperite Group
ArunA Biomedical
Evox Therapeutics
NeurExo Sciences
Tavec Pharmaceuticals
AEGLE Therapeutics
Avalon GloboCare
AlligatorBioscience
Capricor Therapeutics
Stem Cell Medicine
CellTex Therapeutics
Segment by Type
Direct Treatment
Drug Delivery Vehicle

Segment by Application


Hospital
Clinic
Research Institutions
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue analysis from 2018 to 2029
Chapter 3Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Product revenue analysis by type from 2018 to 2029 globally
Chapter 5Product revenue analysis by application from 2018 to 2029 globally
Chapter 6Product revenue analysis by type and application from 2018 to 2029 in US & Canada. Product revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product revenue analysis by type and application from 2018 to 2029 in Europe. Product revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product revenue analysis by type and application from 2018 to 2029 in China. Product revenue analysis of China from 2018 to 2029
Chapter 9Product revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Companies’ outline, covering company’s basic information, major business, Exosome Therapy introduction, etc. Exosome Therapy Revenue and Gross Margin of each company from 2018 to 2024
Chapter 12Mr Accuracy reports Conclusions of Exosome Therapy
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Exosome Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Direct Treatment
1.2.3 Drug Delivery Vehicle
1.3 Market by Application
1.3.1 Global Exosome Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Exosome Therapy Market Perspective (2018-2029)
2.2 Global Exosome Therapy Growth Trends by Region
2.2.1 Exosome Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Exosome Therapy Historic Market Size by Region (2018-2024)
2.2.3 Exosome Therapy Forecasted Market Size by Region (2024-2029)
2.3 Exosome Therapy Market Dynamics
2.3.1 Exosome Therapy Industry Trends
2.3.2 Exosome Therapy Market Drivers
2.3.3 Exosome Therapy Market Challenges
2.3.4 Exosome Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Exosome Therapy by Players
3.1.1 Global Exosome Therapy Revenue by Players (2018-2024)
3.1.2 Global Exosome Therapy Revenue Market Share by Players (2018-2024)
3.2 Global Exosome Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Exosome Therapy, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Exosome Therapy Market Concentration Ratio
3.4.1 Global Exosome Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Exosome Therapy Revenue in 2022
3.5 Global Key Players of Exosome Therapy Head office and Area Served
3.6 Global Key Players of Exosome Therapy, Product and Application
3.7 Global Key Players of Exosome Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Exosome Therapy Breakdown Data by Type
4.1 Global Exosome Therapy Historic Market Size by Type (2018-2024)
4.2 Global Exosome Therapy Forecasted Market Size by Type (2024-2029)
5 Exosome Therapy Breakdown Data by Application
5.1 Global Exosome Therapy Historic Market Size by Application (2018-2024)
5.2 Global Exosome Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Exosome Therapy Market Size (2018-2029)
6.2 North America Exosome Therapy Market Size by Type
6.2.1 North America Exosome Therapy Market Size by Type (2018-2024)
6.2.2 North America Exosome Therapy Market Size by Type (2024-2029)
6.2.3 North America Exosome Therapy Market Share by Type (2018-2029)
6.3 North America Exosome Therapy Market Size by Application
6.3.1 North America Exosome Therapy Market Size by Application (2018-2024)
6.3.2 North America Exosome Therapy Market Size by Application (2024-2029)
6.3.3 North America Exosome Therapy Market Share by Application (2018-2029)
6.4 North America Exosome Therapy Market Size by Country
6.4.1 North America Exosome Therapy Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Exosome Therapy Market Size by Country (2018-2024)
6.4.3 North America Exosome Therapy Market Size by Country (2024-2029)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Exosome Therapy Market Size (2018-2029)
7.2 Europe Exosome Therapy Market Size by Type
7.2.1 Europe Exosome Therapy Market Size by Type (2018-2024)
7.2.2 Europe Exosome Therapy Market Size by Type (2024-2029)
7.2.3 Europe Exosome Therapy Market Share by Type (2018-2029)
7.3 Europe Exosome Therapy Market Size by Application
7.3.1 Europe Exosome Therapy Market Size by Application (2018-2024)
7.3.2 Europe Exosome Therapy Market Size by Application (2024-2029)
7.3.3 Europe Exosome Therapy Market Share by Application (2018-2029)
7.4 Europe Exosome Therapy Market Size by Country
7.4.1 Europe Exosome Therapy Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Exosome Therapy Market Size by Country (2018-2024)
7.4.3 Europe Exosome Therapy Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Exosome Therapy Market Size (2018-2029)
8.2 China Exosome Therapy Market Size by Type
8.2.1 China Exosome Therapy Market Size by Type (2018-2024)
8.2.2 China Exosome Therapy Market Size by Type (2024-2029)
8.2.3 China Exosome Therapy Market Share by Type (2018-2029)
8.3 China Exosome Therapy Market Size by Application
8.3.1 China Exosome Therapy Market Size by Application (2018-2024)
8.3.2 China Exosome Therapy Market Size by Application (2024-2029)
8.3.3 China Exosome Therapy Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Exosome Therapy Market Size (2018-2029)
9.2 Asia Exosome Therapy Market Size by Type
9.2.1 Asia Exosome Therapy Market Size by Type (2018-2024)
9.2.2 Asia Exosome Therapy Market Size by Type (2024-2029)
9.2.3 Asia Exosome Therapy Market Share by Type (2018-2029)
9.3 Asia Exosome Therapy Market Size by Application
9.3.1 Asia Exosome Therapy Market Size by Application (2018-2024)
9.3.2 Asia Exosome Therapy Market Size by Application (2024-2029)
9.3.3 Asia Exosome Therapy Market Share by Application (2018-2029)
9.4 Asia Exosome Therapy Market Size by Region
9.4.1 Asia Exosome Therapy Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Exosome Therapy Market Size by Region (2018-2024)
9.4.3 Asia Exosome Therapy Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Exosome Therapy Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Exosome Therapy Market Size by Type
10.2.1 Middle East, Africa, and Latin America Exosome Therapy Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Exosome Therapy Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Exosome Therapy Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Exosome Therapy Market Size by Application
10.3.1 Middle East, Africa, and Latin America Exosome Therapy Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Exosome Therapy Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Exosome Therapy Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Exosome Therapy Market Size by Country
10.4.1 Middle East, Africa, and Latin America Exosome Therapy Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Exosome Therapy Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Exosome Therapy Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 United Therapeutics Corporation
11.1.1 United Therapeutics Corporation Company Details
11.1.2 United Therapeutics Corporation Business Overview
11.1.3 United Therapeutics Corporation Exosome Therapy Introduction
11.1.4 United Therapeutics Corporation Revenue in Exosome Therapy Business (2018-2024)
11.1.5 United Therapeutics Corporation Recent Developments
11.2 Codiak BioSciences
11.2.1 Codiak BioSciences Company Details
11.2.2 Codiak BioSciences Business Overview
11.2.3 Codiak BioSciences Exosome Therapy Introduction
11.2.4 Codiak BioSciences Revenue in Exosome Therapy Business (2018-2024)
11.2.5 Codiak BioSciences Recent Developments
11.3 EngEx™
11.3.1 EngEx™ Company Details
11.3.2 EngEx™ Business Overview
11.3.3 EngEx™ Exosome Therapy Introduction
11.3.4 EngEx™ Revenue in Exosome Therapy Business (2018-2024)
11.3.5 EngEx™ Recent Developments
11.4 Esperite Group
11.4.1 Esperite Group Company Details
11.4.2 Esperite Group Business Overview
11.4.3 Esperite Group Exosome Therapy Introduction
11.4.4 Esperite Group Revenue in Exosome Therapy Business (2018-2024)
11.4.5 Esperite Group Recent Developments
11.5 ArunA Biomedical
11.5.1 ArunA Biomedical Company Details
11.5.2 ArunA Biomedical Business Overview
11.5.3 ArunA Biomedical Exosome Therapy Introduction
11.5.4 ArunA Biomedical Revenue in Exosome Therapy Business (2018-2024)
11.5.5 ArunA Biomedical Recent Developments
11.6 Evox Therapeutics
11.6.1 Evox Therapeutics Company Details
11.6.2 Evox Therapeutics Business Overview
11.6.3 Evox Therapeutics Exosome Therapy Introduction
11.6.4 Evox Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.6.5 Evox Therapeutics Recent Developments
11.7 NeurExo Sciences
11.7.1 NeurExo Sciences Company Details
11.7.2 NeurExo Sciences Business Overview
11.7.3 NeurExo Sciences Exosome Therapy Introduction
11.7.4 NeurExo Sciences Revenue in Exosome Therapy Business (2018-2024)
11.7.5 NeurExo Sciences Recent Developments
11.8 Tavec Pharmaceuticals
11.8.1 Tavec Pharmaceuticals Company Details
11.8.2 Tavec Pharmaceuticals Business Overview
11.8.3 Tavec Pharmaceuticals Exosome Therapy Introduction
11.8.4 Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2018-2024)
11.8.5 Tavec Pharmaceuticals Recent Developments
11.9 AEGLE Therapeutics
11.9.1 AEGLE Therapeutics Company Details
11.9.2 AEGLE Therapeutics Business Overview
11.9.3 AEGLE Therapeutics Exosome Therapy Introduction
11.9.4 AEGLE Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.9.5 AEGLE Therapeutics Recent Developments
11.10 Avalon GloboCare
11.10.1 Avalon GloboCare Company Details
11.10.2 Avalon GloboCare Business Overview
11.10.3 Avalon GloboCare Exosome Therapy Introduction
11.10.4 Avalon GloboCare Revenue in Exosome Therapy Business (2018-2024)
11.10.5 Avalon GloboCare Recent Developments
11.11 AlligatorBioscience
11.11.1 AlligatorBioscience Company Details
11.11.2 AlligatorBioscience Business Overview
11.11.3 AlligatorBioscience Exosome Therapy Introduction
11.11.4 AlligatorBioscience Revenue in Exosome Therapy Business (2018-2024)
11.11.5 AlligatorBioscience Recent Developments
11.12 Capricor Therapeutics
11.12.1 Capricor Therapeutics Company Details
11.12.2 Capricor Therapeutics Business Overview
11.12.3 Capricor Therapeutics Exosome Therapy Introduction
11.12.4 Capricor Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.12.5 Capricor Therapeutics Recent Developments
11.13 Stem Cell Medicine
11.13.1 Stem Cell Medicine Company Details
11.13.2 Stem Cell Medicine Business Overview
11.13.3 Stem Cell Medicine Exosome Therapy Introduction
11.13.4 Stem Cell Medicine Revenue in Exosome Therapy Business (2018-2024)
11.13.5 Stem Cell Medicine Recent Developments
11.14 CellTex Therapeutics
11.14.1 CellTex Therapeutics Company Details
11.14.2 CellTex Therapeutics Business Overview
11.14.3 CellTex Therapeutics Exosome Therapy Introduction
11.14.4 CellTex Therapeutics Revenue in Exosome Therapy Business (2018-2024)
11.14.5 CellTex Therapeutics Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Exosome Therapy Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
Table 2. Key Players of Direct Treatment
Table 3. Key Players of Drug Delivery Vehicle
Table 4. Global Exosome Therapy Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
Table 5. Global Exosome Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 6. Global Exosome Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 7. Global Exosome Therapy Market Share by Region (2018-2024)
Table 8. Global Exosome Therapy Forecasted Market Size by Region (2024-2029) & (US$ Million)
Table 9. Global Exosome Therapy Market Share by Region (2024-2029)
Table 10. Exosome Therapy Market Trends
Table 11. Exosome Therapy Market Drivers
Table 12. Exosome Therapy Market Challenges
Table 13. Exosome Therapy Market Restraints
Table 14. Global Exosome Therapy Revenue by Players (2018-2024) & (US$ Million)
Table 15. Global Exosome Therapy Revenue Share by Players (2018-2024)
Table 16. Global Top Exosome Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2022)
Table 17. Global Exosome Therapy Industry Ranking 2021 VS 2022 VS 2024
Table 18. Global 5 Largest Players Market Share by Exosome Therapy Revenue (CR5 and HHI) & (2018-2024)
Table 19. Global Key Players of Exosome Therapy, Headquarters and Area Served
Table 20. Global Key Players of Exosome Therapy, Product and Application
Table 21. Global Key Players of Exosome Therapy, Product and Application
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 24. Global Exosome Therapy Revenue Market Share by Type (2018-2024)
Table 25. Global Exosome Therapy Forecasted Market Size by Type (2024-2029) & (US$ Million)
Table 26. Global Exosome Therapy Revenue Market Share by Type (2024-2029)
Table 27. Global Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 28. Global Exosome Therapy Revenue Share by Application (2018-2024)
Table 29. Global Exosome Therapy Forecasted Market Size by Application (2024-2029) & (US$ Million)
Table 30. Global Exosome Therapy Revenue Share by Application (2024-2029)
Table 31. North America Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 32. North America Exosome Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 33. North America Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 34. North America Exosome Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 35. North America Exosome Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 36. North America Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 37. North America Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 38. Europe Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 39. Europe Exosome Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 40. Europe Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 41. Europe Exosome Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 42. Europe Exosome Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 43. Europe Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 44. Europe Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 45. China Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 46. China Exosome Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 47. China Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 48. China Exosome Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 49. Asia Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 50. Asia Exosome Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 51. Asia Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 52. Asia Exosome Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 53. Asia Exosome Therapy Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
Table 54. Asia Exosome Therapy Market Size by Region (2018-2024) & (US$ Million)
Table 55. Asia Exosome Therapy Market Size by Region (2024-2029) & (US$ Million)
Table 56. Middle East, Africa, and Latin America Exosome Therapy Market Size by Type (2018-2024) & (US$ Million)
Table 57. Middle East, Africa, and Latin America Exosome Therapy Market Size by Type (2024-2029) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Exosome Therapy Market Size by Application (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Exosome Therapy Market Size by Application (2024-2029) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Exosome Therapy Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
Table 61. Middle East, Africa, and Latin America Exosome Therapy Market Size by Country (2018-2024) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Exosome Therapy Market Size by Country (2024-2029) & (US$ Million)
Table 63. United Therapeutics Corporation Company Details
Table 64. United Therapeutics Corporation Business Overview
Table 65. United Therapeutics Corporation Exosome Therapy Product
Table 66. United Therapeutics Corporation Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 67. United Therapeutics Corporation Recent Developments
Table 68. Codiak BioSciences Company Details
Table 69. Codiak BioSciences Business Overview
Table 70. Codiak BioSciences Exosome Therapy Product
Table 71. Codiak BioSciences Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 72. Codiak BioSciences Recent Developments
Table 73. EngEx™ Company Details
Table 74. EngEx™ Business Overview
Table 75. EngEx™ Exosome Therapy Product
Table 76. EngEx™ Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 77. EngEx™ Recent Developments
Table 78. Esperite Group Company Details
Table 79. Esperite Group Business Overview
Table 80. Esperite Group Exosome Therapy Product
Table 81. Esperite Group Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 82. Esperite Group Recent Developments
Table 83. ArunA Biomedical Company Details
Table 84. ArunA Biomedical Business Overview
Table 85. ArunA Biomedical Exosome Therapy Product
Table 86. ArunA Biomedical Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 87. ArunA Biomedical Recent Developments
Table 88. Evox Therapeutics Company Details
Table 89. Evox Therapeutics Business Overview
Table 90. Evox Therapeutics Exosome Therapy Product
Table 91. Evox Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 92. Evox Therapeutics Recent Developments
Table 93. NeurExo Sciences Company Details
Table 94. NeurExo Sciences Business Overview
Table 95. NeurExo Sciences Exosome Therapy Product
Table 96. NeurExo Sciences Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 97. NeurExo Sciences Recent Developments
Table 98. Tavec Pharmaceuticals Company Details
Table 99. Tavec Pharmaceuticals Business Overview
Table 100. Tavec Pharmaceuticals Exosome Therapy Product
Table 101. Tavec Pharmaceuticals Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 102. Tavec Pharmaceuticals Recent Developments
Table 103. AEGLE Therapeutics Company Details
Table 104. AEGLE Therapeutics Business Overview
Table 105. AEGLE Therapeutics Exosome Therapy Product
Table 106. AEGLE Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 107. AEGLE Therapeutics Recent Developments
Table 108. Avalon GloboCare Company Details
Table 109. Avalon GloboCare Business Overview
Table 110. Avalon GloboCare Exosome Therapy Product
Table 111. Avalon GloboCare Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 112. Avalon GloboCare Recent Developments
Table 113. AlligatorBioscience Company Details
Table 114. AlligatorBioscience Business Overview
Table 115. AlligatorBioscience Exosome Therapy Product
Table 116. AlligatorBioscience Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 117. AlligatorBioscience Recent Developments
Table 118. Capricor Therapeutics Company Details
Table 119. Capricor Therapeutics Business Overview
Table 120. Capricor Therapeutics Exosome Therapy Product
Table 121. Capricor Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 122. Capricor Therapeutics Recent Developments
Table 123. Stem Cell Medicine Company Details
Table 124. Stem Cell Medicine Business Overview
Table 125. Stem Cell Medicine Exosome Therapy Product
Table 126. Stem Cell Medicine Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 127. Stem Cell Medicine Recent Developments
Table 128. CellTex Therapeutics Company Details
Table 129. CellTex Therapeutics Business Overview
Table 130. CellTex Therapeutics Exosome Therapy Product
Table 131. CellTex Therapeutics Revenue in Exosome Therapy Business (2018-2024) & (US$ Million)
Table 132. CellTex Therapeutics Recent Developments
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Exosome Therapy Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 2. Global Exosome Therapy Market Share by Type: 2022 VS 2029
Figure 3. Direct Treatment Features
Figure 4. Drug Delivery Vehicle Features
Figure 5. Global Exosome Therapy Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 6. Global Exosome Therapy Market Share by Application: 2022 VS 2029
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Research Institutions Case Studies
Figure 10. Exosome Therapy Report Years Considered
Figure 11. Global Exosome Therapy Market Size (US$ Million), Year-over-Year: 2018-2029
Figure 12. Global Exosome Therapy Market Size, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Exosome Therapy Market Share by Region: 2022 VS 2029
Figure 14. Global Exosome Therapy Market Share by Players in 2022
Figure 15. Global Top Exosome Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Exosome Therapy as of 2022)
Figure 16. The Top 10 and 5 Players Market Share by Exosome Therapy Revenue in 2022
Figure 17. North America Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 18. North America Exosome Therapy Market Share by Type (2018-2029)
Figure 19. North America Exosome Therapy Market Share by Application (2018-2029)
Figure 20. North America Exosome Therapy Market Share by Country (2018-2029)
Figure 21. United States Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 22. Canada Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 23. Europe Exosome Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 24. Europe Exosome Therapy Market Share by Type (2018-2029)
Figure 25. Europe Exosome Therapy Market Share by Application (2018-2029)
Figure 26. Europe Exosome Therapy Market Share by Country (2018-2029)
Figure 27. Germany Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 28. France Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 29. U.K. Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 30. Italy Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 31. Russia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 32. Nordic Countries Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 33. China Exosome Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 34. China Exosome Therapy Market Share by Type (2018-2029)
Figure 35. China Exosome Therapy Market Share by Application (2018-2029)
Figure 36. Asia Exosome Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 37. Asia Exosome Therapy Market Share by Type (2018-2029)
Figure 38. Asia Exosome Therapy Market Share by Application (2018-2029)
Figure 39. Asia Exosome Therapy Market Share by Region (2018-2029)
Figure 40. Japan Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 41. South Korea Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 42. China Taiwan Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 44. India Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 45. Australia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 46. Middle East, Africa, and Latin America Exosome Therapy Market Size YoY (2018-2029) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Exosome Therapy Market Share by Type (2018-2029)
Figure 48. Middle East, Africa, and Latin America Exosome Therapy Market Share by Application (2018-2029)
Figure 49. Middle East, Africa, and Latin America Exosome Therapy Market Share by Country (2018-2029)
Figure 50. Brazil Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 51. Mexico Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 52. Turkey Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 54. Israel Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 55. GCC Countries Exosome Therapy Market Size YoY Growth (2018-2029) & (US$ Million)
Figure 56. United Therapeutics Corporation Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 57. Codiak BioSciences Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 58. EngEx™ Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 59. Esperite Group Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 60. ArunA Biomedical Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 61. Evox Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 62. NeurExo Sciences Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 63. Tavec Pharmaceuticals Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 64. AEGLE Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 65. Avalon GloboCare Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 66. AlligatorBioscience Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 67. Capricor Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 68. Stem Cell Medicine Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 69. CellTex Therapeutics Revenue Growth Rate in Exosome Therapy Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries